{ "cik": 1446847, "cik_padded": "0001446847", "entityName": "IRONWOOD PHARMACEUTICALS INC", "fiscal_years": [ { "accn": "0001104659-26-020489", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 34000.0, "cash": 215456000.0, "eps_diluted": 0.15, "free_cash_flow": 127010000.0, "net_income": 24017000.0, "operating_cash_flow": 127044000.0, "operating_income": 98502000.0, "revenue": 296151000.0, "stockholders_equity": -261835000.0, "total_assets": 396901000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.08109714301150425, "operating_margin": 0.332607352330399, "revenue_growth_yoy": -0.15724936683645885, "roa_avg2y": 0.06423297927679394, "roa_period_end": 0.06051131138495494, "roe_avg2y": -0.08529218530816628 } }, { "accn": "0001104659-26-020489", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 142000.0, "cash": 88559000.0, "eps_diluted": 0.01, "free_cash_flow": 103407000.0, "net_income": 880000.0, "operating_cash_flow": 103549000.0, "operating_income": 93124000.0, "revenue": 351410000.0, "stockholders_equity": -301335000.0, "total_assets": 350908000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.0025041973762841125, "operating_margin": 0.26500099598759286, "revenue_growth_yoy": -0.20627463381029285, "roa_avg2y": 0.002141168713145438, "roa_period_end": 0.0025077798169320735, "roe_avg2y": -0.002717601099393172 } }, { "accn": "0001558370-25-004072", "filed": "2025-03-31", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 273000.0, "cash": 92154000.0, "eps_diluted": -6.45, "free_cash_flow": 183154000.0, "net_income": -1002239000.0, "operating_cash_flow": 183427000.0, "operating_income": -945430000.0, "revenue": 442735000.0, "stockholders_equity": -346295000.0, "total_assets": 471073000.0 }, "period_end": "2023-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.0782740211789691, "roa_avg2y": -1.2754442628875688, "roe_avg2y": -6.548805389387846 } }, { "accn": "0001558370-25-004072", "filed": "2025-03-31", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 136000.0, "cash": 656203000.0, "eps_diluted": 0.96, "free_cash_flow": 273627000.0, "net_income": 175065000.0, "operating_cash_flow": 273763000.0, "operating_income": 250337000.0, "revenue": 410596000.0, "stockholders_equity": 652378000.0, "total_assets": 1100519000.0 }, "period_end": "2022-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.4263680113785814, "operating_margin": 0.6096917651414042, "roa_avg2y": 0.15718899582750828, "roa_period_end": 0.15907494554841853, "roe_avg2y": 0.278258810177948 } }, { "accn": "0001558370-24-001275", "filed": "2024-02-16", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 265000.0, "cash": 620129000.0, "eps_diluted": 3.21, "free_cash_flow": 261630000.0, "net_income": 528448000.0, "operating_cash_flow": 261895000.0, "operating_income": 232259000.0, "stockholders_equity": 605911000.0, "total_assets": 1126927000.0 }, "period_end": "2021-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": 0.6268046128344498, "roa_period_end": 0.46892833342354917, "roe_avg2y": 1.580875654961252 } }, { "accn": "0001558370-23-001462", "filed": "2023-02-16", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1842000.0, "cash": 362564000.0, "eps_diluted": 0.66, "free_cash_flow": 166994000.0, "net_income": 106176000.0, "operating_cash_flow": 168836000.0, "operating_income": 142940000.0, "revenue": 389523000.0, "stockholders_equity": 62640000.0, "total_assets": 559238000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.2725795395907302, "operating_margin": 0.36696164282982013, "revenue_growth_yoy": -0.09077689052386366, "roa_avg2y": 0.2207433372211238, "roa_period_end": 0.18985834295952705, "roe_avg2y": -6.937114109307112 } }, { "accn": "0001558370-22-001368", "filed": "2022-02-18", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 7189000.0, "cash": 177023000.0, "eps_diluted": 0.14, "free_cash_flow": 3536000.0, "net_income": 21505000.0, "operating_cash_flow": 10725000.0, "operating_income": 120123000.0, "revenue": 428413000.0, "stockholders_equity": -93251000.0, "total_assets": 402748000.0 }, "period_end": "2019-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": 0.0501968894501334, "operating_margin": 0.2803906510773483, "revenue_growth_yoy": 0.23590536552436397, "roa_avg2y": 0.05853309344881178, "roa_period_end": 0.05339567173517932, "roe_avg2y": -0.1485039119956357 } }, { "accn": "0001558370-22-001368", "filed": "2022-02-18", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 351000.0, "cash": 173172000.0, "eps_diluted": -1.85, "free_cash_flow": -71233000.0, "net_income": -282368000.0, "operating_cash_flow": -70882000.0, "operating_income": -150670000.0, "revenue": 346639000.0, "stockholders_equity": -196371000.0, "total_assets": 332050000.0 }, "period_end": "2018-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.8145880873185072, "operating_margin": -0.43465968918673314, "revenue_growth_yoy": 0.1621417747321273, "roa_avg2y": -0.6022411711761669, "roa_period_end": -0.8503779551272399, "roe_avg2y": 3.0277016775411076 } }, { "accn": "0001558370-21-001136", "filed": "2021-02-17", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 2803000.0, "cash": 125736000.0, "free_cash_flow": -103556000.0, "net_income": -116937000.0, "operating_cash_flow": -100753000.0, "operating_income": -15363000.0, "revenue": 298276000.0, "stockholders_equity": 9848000.0, "total_assets": 605674000.0 }, "period_end": "2017-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.39204294009575025, "operating_margin": -0.05150598774289584, "revenue_growth_yoy": 0.08876940541763853, "roa_avg2y": -0.17778402806548105, "roa_period_end": -0.19306920884832438, "roe_avg2y": -3.0546209706911864 } }, { "accn": "0001558370-20-000779", "filed": "2020-02-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 4206000.0, "cash": 54004000.0, "free_cash_flow": -30140000.0, "net_income": -81708000.0, "operating_cash_flow": -25934000.0, "operating_income": -51870000.0, "revenue": 273957000.0, "stockholders_equity": 66716000.0, "total_assets": 709821000.0 }, "period_end": "2016-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio" }, "ratios": { "net_margin": -0.29825118540500883, "operating_margin": -0.18933628270129982, "roa_period_end": -0.11511071101024059 } }, { "accn": "0001047469-14-000693", "filed": "2014-02-07", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -2.35 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0001047469-14-000693", "filed": "2014-02-07", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.68 }, "period_end": "2012-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001104659-26-020489", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001446847.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001446847.json" }, "ticker": "IRWD" }